Alvotech was classified in the Biomedical and Genetics industry by Zacks Medical.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alvotech was classified in the Biomedical and Genetics industry by Zacks Medical.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Alvotech announced significant operational developments, including reported results from Reykjavik, Iceland, and acquisitions of R&D facilities in Sweden and Ivers-Lee Group in Switzerland.Sub-event
Alvotech is categorized in the Biomedical and Genetics industry by Zacks Medical.1 source
Keep exploring
The entities involved
-
Alvotech
biotechnology company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- ZacksAlvotech (ALVO) Q2 Earnings and Revenues Beat Estimates Alvotech (ALVO) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.26 per share. This co